Germline mutations in BRCA1 and BRCA2 confer an estimated 65 and 45% cumulative lifetime risk of developing breast cancer, and an ovarian cancer risk of 39 and 11%, respectively (Antoniou et al, 2003). The gene discussed is BRCA1; the disease is breast cancer.